Focus

Ensitrelvir

Asia & Pacific
Asia & Pacific

Japanese Company Says New Oral COVID-19 Drug Ensitrelvir Achieves Primary Endpoint

Japanese Company Says New Oral COVID-19 Drug Ensitrelvir Achieves Primary Endpoint
|